Aurora Cannabis Inc.

• 

  Aurora Cannabis Starts Trading on Toronto Stock Exchange

  10:44 AM | July 21, 2017

  Company Will Ring the Bell to Open the Market Monday, July 24 TSXV: ACB VANCOUVER, July 21, 2017, ACBFF, ACB, /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that common shares of the Company will commence trading on Toronto Stock Exchange (the “TSX”) effective Monday July 24. Common shares will continue to trade under the symbol “ACB”. In conjunction with listing on TSX, the common shares have been voluntarily delisted from TSX Venture Exchange, effective

  Read more
• 

  Aurora Cannabis Passes First Stage of German Domestic Production Tender Application Process

  11:37 AM | July 12, 2017

  VANCOUVER, July 12, 2017 TSXV: ACB VANCOUVER, July 12, 2017, ACBFF, /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that its wholly owned subsidiary Pedanios GmbH (“Pedanios”) has successfully passed the first stage of the tender application process to become a licensed producer of medical cannabis in Germany. As a result of initial stage evaluations, the German Federal Institute for Medicines and Medical Products (“BfArM”), has requested Pedanios’ participation in

  Read more
• 

  Operational Update: Aurora Cannabis Surpasses 16,000 Registered Patients; Launch of Cannabis Oils Drives Record Monthly Revenue

  11:28 AM | June 29, 2017

  VANCOUVER, June 29, 2017, ACB, ACBFF, TSXV: ACB VANCOUVER, June 29, 2017 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update: Patient Registration Accelerates As of June 29, 2017, Aurora has surpassed 16,000 active registered patients less than 18 months after the Company’s first product sale in January, 2016. Registration accelerated in the months of May and June, 2017, adding approximately 3,000 patients during

  Read more
• 

  Aurora to Acquire Peloton Pharmaceuticals Inc.

  3:33 PM | March 6, 2017

  VANCOUVER, March 6, 2017 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that its proposal (the “Proposal”) to acquire Peloton Pharmaceuticals Inc. (“Peloton”), a late-stage ACMPR-applicant, out of bankruptcy protection was approved by Peloton’s creditors at a recent meeting (the “Creditor Meeting”). Peloton is constructing a 40,000 square foot cannabis production facility in Pointe Claire, Quebec, which received a “ready to build” letter from Health Canada in

  Read more
• 

  Aurora Receives Health Canada License to Sell Cannabis Oils

  12:20 PM | January 23, 2017

  VANCOUVER, Jan. 23, 2017 TSXV: ACB, OTCQB: ACBFF VANCOUVER, Jan. 23, 2017 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce that on January 20, 2017, its wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., a licensed producer and distributor of medical cannabis, was licensed by Health Canada for the sale of cannabis oils. The Company received its cannabis oils production license in February 2016, and in anticipation of receiving its

  Read more
• 

  Operational Update: Aurora Cannabis Surpasses 12,000 Registered Patients in First 12 Months of Product Sales

  1:45 PM | January 16, 2017

  Canada NewsWire, ACBFF VANCOUVER, Jan. 16, 2017 TSXV: ACB VANCOUVER, Jan. 16, 2017 /CNW/ – Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSXV: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) is pleased to provide the following operational update. Patient Registration Continues Rapid Pace On December 21, 2016, Aurora surpassed 12,000 active registered patients, less than 12 months after the Company’s first product sale in January, 2016, which is believed to be the fastest rate of patient registration after commencement of

  Read more